Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
Primary and secondary outcome measures in the present analysis were the same as those described in the primary trial results.18 The primary end point was a composite of death due to cardiovascular causes, nonfatal MI, and nonfatal stroke. Other major end points included a composite of cardiovascular mortality or hospitalization for heart failure and all‐cause mortality or hospitalization for heart failure.19, 20 Cardiovascular events were prospectively adjudicated by an end points committee (C5, Cleveland Clinic, Cleveland, Ohio) blinded to treatment assignment.
Copyright and License information: ©2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
